- Helps in controlling blood sugar levels in patients with type 2 diabetes.
- Reduces the risk of diabetes-related complications by maintaining glycemic control.
- Improves insulin sensitivity and decreases hepatic glucose production.
- Stimulates insulin secretion from the pancreas to enhance glucose uptake.
- Slows down carbohydrate absorption in the intestines, preventing postprandial spikes in blood sugar.
- Can be used in conjunction with diet and exercise for better diabetes management.
- May help in weight management as part of a comprehensive diabetes treatment plan.
Glimisave MV 3.3 F Tablet - Strip of 15
Prescription Required
Compositions : Glimepiride 3mg + Metformin 1000mg + Voglibose 0.3mg
₹209.29
(Incl. GST)
MRP :
(Incl. GST)
MRP :
In stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: Eris Lifesciences Limited
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
Glimisave MV 3.3 F Tablet is a pharmaceutical product designed to assist in the management of diabetes mellitus, particularly type 2 diabetes. This medication combines multiple active ingredients that work synergistically to help control blood sugar levels in patients. The primary components of Glimisave MV 3.3 F Tablet include Metformin, Glimepiride, and Voglibose, each contributing to its therapeutic efficacy. Metformin is known for its ability to decrease hepatic glucose production and improve insulin sensitivity, while Glimepiride stimulates insulin secretion from the pancreas. Voglibose, an alpha-glucosidase inhibitor, slows down carbohydrate absorption in the intestines, further aiding in blood sugar control. Together, these ingredients provide a comprehensive approach to managing diabetes, making Glimisave MV 3.3 F Tablet a valuable option for patients seeking effective glycemic control. The formulation is designed for oral administration and is typically prescribed as part of a broader diabetes management plan that includes dietary modifications and physical activity. By addressing multiple pathways involved in glucose metabolism, Glimisave MV 3.3 F Tablet helps patients achieve better overall glycemic control and reduce the risk of diabetes-related complications. It is essential for patients to follow their healthcare provider's instructions regarding the use of this medication to ensure optimal results and minimize potential side effects.
Product Details
Uses & Benefits
How Glimisave MV 3.3 F Tablet works
- Metformin decreases glucose production in the liver and increases insulin sensitivity.
- Glimepiride stimulates pancreatic beta cells to release more insulin.
- Voglibose inhibits alpha-glucosidase enzymes, slowing carbohydrate digestion and absorption.
- Together, these actions help lower blood glucose levels effectively.
- The combination therapy addresses multiple mechanisms of diabetes management.
How to use Glimisave MV 3.3 F Tablet
- Take Glimisave MV 3.3 F Tablet orally with a glass of water.
- Dosage is typically prescribed by a healthcare provider based on individual needs.
- Commonly recommended dosage is one tablet taken once daily.
- It is advisable to take the tablet with meals to minimize gastrointestinal side effects.
- Do not exceed the prescribed dosage without consulting your doctor.
- Regular monitoring of blood glucose levels is recommended during treatment.
- Follow your healthcare provider's instructions regarding the duration of therapy.
Lifestyle Advice
- Maintain a balanced diet rich in whole grains, vegetables, and lean proteins.
- Engage in regular physical activity, aiming for at least 150 minutes of moderate exercise weekly.
- Monitor blood sugar levels regularly to track your response to the medication.
- Avoid excessive consumption of sugary foods and beverages that can spike blood sugar levels.
- Stay hydrated by drinking plenty of water throughout the day.
- Consider working with a dietitian to create a personalized meal plan that complements your medication regimen.
Safety Advice
Side Effects
- Common side effects may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain.
- Some patients may experience dizziness or headache as a result of medication use.
- Serious side effects can include hypoglycemia (low blood sugar), which may present as sweating, shaking, confusion, or irritability.
- If you experience symptoms of lactic acidosis such as unusual muscle pain, difficulty breathing, or feeling cold, seek medical attention immediately.
- Allergic reactions are rare but can occur; watch for signs like rash, itching, or swelling.
Precautions and Warnings
- Avoid alcohol consumption while taking Glimisave MV 3.3 F Tablet as it may increase the risk of lactic acidosis.
- Consult your doctor if you are pregnant or breastfeeding before using this medication.
- Patients with severe kidney or liver impairment should not use Glimisave MV 3.3 F Tablet due to increased risk of side effects.
- Monitor blood sugar levels regularly to avoid hypoglycemia while on this medication.
- If you experience symptoms of low blood sugar, such as dizziness or confusion, seek immediate medical assistance.
FAQs
1. What should I do if I miss a dose of Glimisave MV 3.3 F Tablet?
If you miss a dose, take it as soon as you remember. If it's almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not double up on doses.
2. Can Glimisave MV 3.3 F Tablet be taken with other medications?
Always inform your healthcare provider about all medications you are taking, as Glimisave MV 3.3 F Tablet may interact with certain drugs.
3. Is it safe to use Glimisave MV 3.3 F Tablet during pregnancy?
Consult your doctor before using Glimisave MV 3.3 F Tablet during pregnancy, as it may not be recommended.
4. How should I store Glimisave MV 3.3 F Tablet?
Store Glimisave MV 3.3 F Tablet at room temperature away from moisture and heat, and keep it out of reach of children.
5. What are the common side effects of Glimisave MV 3.3 F Tablet?
Common side effects may include nausea, vomiting, diarrhea, and abdominal discomfort. If these persist or worsen, contact your healthcare provider.
6. Who should avoid taking Glimisave MV 3.3 F Tablet?
Individuals with a known allergy to any component of Glimisave MV 3.3 F Tablet or those with severe kidney or liver impairment should avoid this medication.
If you miss a dose, take it as soon as you remember. If it's almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not double up on doses.
2. Can Glimisave MV 3.3 F Tablet be taken with other medications?
Always inform your healthcare provider about all medications you are taking, as Glimisave MV 3.3 F Tablet may interact with certain drugs.
3. Is it safe to use Glimisave MV 3.3 F Tablet during pregnancy?
Consult your doctor before using Glimisave MV 3.3 F Tablet during pregnancy, as it may not be recommended.
4. How should I store Glimisave MV 3.3 F Tablet?
Store Glimisave MV 3.3 F Tablet at room temperature away from moisture and heat, and keep it out of reach of children.
5. What are the common side effects of Glimisave MV 3.3 F Tablet?
Common side effects may include nausea, vomiting, diarrhea, and abdominal discomfort. If these persist or worsen, contact your healthcare provider.
6. Who should avoid taking Glimisave MV 3.3 F Tablet?
Individuals with a known allergy to any component of Glimisave MV 3.3 F Tablet or those with severe kidney or liver impairment should avoid this medication.
Instructions
Directions for Use
Use only as prescribed by your physician.
Storage and Disposal
Please refer to the product label for storage information.
More Information
| SKU | 125088 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Eris Lifesciences Limited |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Glimisave MV 3.3 F Tablet is a pharmaceutical product designed to assist in the management of diabetes mellitus, particularly type 2 diabetes. This medication combines multiple active ingredients that work synergistically to help control blood sugar levels in patients. The primary components of Glimisave MV 3.3 F Tablet include Metformin, Glimepiride, and Voglibose, each contributing to its therapeutic efficacy. Metformin is known for its ability to decrease hepatic glucose production and improve insulin sensitivity, while Glimepiride stimulates insulin secretion from the pancreas. Voglibose, an alpha-glucosidase inhibitor, slows down carbohydrate absorption in the intestines, further aiding in blood sugar control. Together, these ingredients provide a comprehensive approach to managing diabetes, making Glimisave MV 3.3 F Tablet a valuable option for patients seeking effective glycemic control. The formulation is designed for oral administration and is typically prescribed as part of a broader diabetes management plan that includes dietary modifications and physical activity. By addressing multiple pathways involved in glucose metabolism, Glimisave MV 3.3 F Tablet helps patients achieve better overall glycemic control and reduce the risk of diabetes-related complications. It is essential for patients to follow their healthcare provider's instructions regarding the use of this medication to ensure optimal results and minimize potential side effects.
Uses & Benefits
- Helps in controlling blood sugar levels in patients with type 2 diabetes.
- Reduces the risk of diabetes-related complications by maintaining glycemic control.
- Improves insulin sensitivity and decreases hepatic glucose production.
- Stimulates insulin secretion from the pancreas to enhance glucose uptake.
- Slows down carbohydrate absorption in the intestines, preventing postprandial spikes in blood sugar.
- Can be used in conjunction with diet and exercise for better diabetes management.
- May help in weight management as part of a comprehensive diabetes treatment plan.
How Glimisave MV 3.3 F Tablet works
- Metformin decreases glucose production in the liver and increases insulin sensitivity.
- Glimepiride stimulates pancreatic beta cells to release more insulin.
- Voglibose inhibits alpha-glucosidase enzymes, slowing carbohydrate digestion and absorption.
- Together, these actions help lower blood glucose levels effectively.
- The combination therapy addresses multiple mechanisms of diabetes management.
How to use Glimisave MV 3.3 F Tablet
- Take Glimisave MV 3.3 F Tablet orally with a glass of water.
- Dosage is typically prescribed by a healthcare provider based on individual needs.
- Commonly recommended dosage is one tablet taken once daily.
- It is advisable to take the tablet with meals to minimize gastrointestinal side effects.
- Do not exceed the prescribed dosage without consulting your doctor.
- Regular monitoring of blood glucose levels is recommended during treatment.
- Follow your healthcare provider's instructions regarding the duration of therapy.
Lifestyle Advice
- Maintain a balanced diet rich in whole grains, vegetables, and lean proteins.
- Engage in regular physical activity, aiming for at least 150 minutes of moderate exercise weekly.
- Monitor blood sugar levels regularly to track your response to the medication.
- Avoid excessive consumption of sugary foods and beverages that can spike blood sugar levels.
- Stay hydrated by drinking plenty of water throughout the day.
- Consider working with a dietitian to create a personalized meal plan that complements your medication regimen.
Side Effects
- Common side effects may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain.
- Some patients may experience dizziness or headache as a result of medication use.
- Serious side effects can include hypoglycemia (low blood sugar), which may present as sweating, shaking, confusion, or irritability.
- If you experience symptoms of lactic acidosis such as unusual muscle pain, difficulty breathing, or feeling cold, seek medical attention immediately.
- Allergic reactions are rare but can occur; watch for signs like rash, itching, or swelling.
Precautions and Warnings
- Avoid alcohol consumption while taking Glimisave MV 3.3 F Tablet as it may increase the risk of lactic acidosis.
- Consult your doctor if you are pregnant or breastfeeding before using this medication.
- Patients with severe kidney or liver impairment should not use Glimisave MV 3.3 F Tablet due to increased risk of side effects.
- Monitor blood sugar levels regularly to avoid hypoglycemia while on this medication.
- If you experience symptoms of low blood sugar, such as dizziness or confusion, seek immediate medical assistance.
1. What should I do if I miss a dose of Glimisave MV 3.3 F Tablet?
If you miss a dose, take it as soon as you remember. If it's almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not double up on doses.
2. Can Glimisave MV 3.3 F Tablet be taken with other medications?
Always inform your healthcare provider about all medications you are taking, as Glimisave MV 3.3 F Tablet may interact with certain drugs.
3. Is it safe to use Glimisave MV 3.3 F Tablet during pregnancy?
Consult your doctor before using Glimisave MV 3.3 F Tablet during pregnancy, as it may not be recommended.
4. How should I store Glimisave MV 3.3 F Tablet?
Store Glimisave MV 3.3 F Tablet at room temperature away from moisture and heat, and keep it out of reach of children.
5. What are the common side effects of Glimisave MV 3.3 F Tablet?
Common side effects may include nausea, vomiting, diarrhea, and abdominal discomfort. If these persist or worsen, contact your healthcare provider.
6. Who should avoid taking Glimisave MV 3.3 F Tablet?
Individuals with a known allergy to any component of Glimisave MV 3.3 F Tablet or those with severe kidney or liver impairment should avoid this medication.
If you miss a dose, take it as soon as you remember. If it's almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not double up on doses.
2. Can Glimisave MV 3.3 F Tablet be taken with other medications?
Always inform your healthcare provider about all medications you are taking, as Glimisave MV 3.3 F Tablet may interact with certain drugs.
3. Is it safe to use Glimisave MV 3.3 F Tablet during pregnancy?
Consult your doctor before using Glimisave MV 3.3 F Tablet during pregnancy, as it may not be recommended.
4. How should I store Glimisave MV 3.3 F Tablet?
Store Glimisave MV 3.3 F Tablet at room temperature away from moisture and heat, and keep it out of reach of children.
5. What are the common side effects of Glimisave MV 3.3 F Tablet?
Common side effects may include nausea, vomiting, diarrhea, and abdominal discomfort. If these persist or worsen, contact your healthcare provider.
6. Who should avoid taking Glimisave MV 3.3 F Tablet?
Individuals with a known allergy to any component of Glimisave MV 3.3 F Tablet or those with severe kidney or liver impairment should avoid this medication.
Directions for Use
Use only as prescribed by your physician.
Storage and Disposal
Please refer to the product label for storage information.
| SKU | 125088 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Eris Lifesciences Limited |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage | Please refer to the product label for storage information. |
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account